Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

Cited In for PubMed (Select 6607655)

1.

The magnetic susceptibility effect of gadolinium-based contrast agents on PRFS-based MR thermometry during thermal interventions.

Hijnen NM, Elevelt A, Pikkemaat J, Bos C, Bartels LW, Grüll H.

J Ther Ultrasound. 2013 Jun 4;1:8. doi: 10.1186/2050-5736-1-8. eCollection 2013.

2.

Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.

Kim SM, Heo SH, Kim JW, Lim HS, Shin SS, Jeong YY, Kang HK.

Korean J Radiol. 2014 Sep-Oct;15(5):605-12. doi: 10.3348/kjr.2014.15.5.605. Epub 2014 Sep 12.

3.

Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.

Tian X, Yang F, Yang C, Peng Y, Chen D, Zhu J, He F, Li L, Chen X.

Int J Nanomedicine. 2014 Aug 21;9:4043-53. doi: 10.2147/IJN.S66164. eCollection 2014.

4.

Use of oral gadobenate dimeglumine to visualise the oesophagus during magnetic resonance angiography in patients with atrial fibrillation prior to catheter ablation.

Faletti R, Rapellino A, Barisone F, Anselmino M, Ferraris F, Fonio P, Gaita F, Gandini G.

J Cardiovasc Magn Reson. 2014 Jun 13;16:41. doi: 10.1186/1532-429X-16-41.

5.

Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.

Kang SG, Araya-Secchi R, Wang D, Wang B, Huynh T, Zhou R.

Sci Rep. 2014 Apr 24;4:4775. doi: 10.1038/srep04775.

6.

Contrast agents for MRI: 30+ years and where are we going?

Pierre VC, Allen MJ, Caravan P.

J Biol Inorg Chem. 2014 Feb;19(2):127-31. doi: 10.1007/s00775-013-1074-5. Epub 2014 Jan 11.

7.

Evidence for two extremes of ciliary motor response in a single swimming microorganism.

Jung I, Powers TR, Valles JM Jr.

Biophys J. 2014 Jan 7;106(1):106-13. doi: 10.1016/j.bpj.2013.11.3703.

8.

Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging.

Xiao J, Tian XM, Yang C, Liu P, Luo NQ, Liang Y, Li HB, Chen DH, Wang CX, Li L, Yang GW.

Sci Rep. 2013 Dec 5;3:3424. doi: 10.1038/srep03424.

9.

Cardiac MR for the assessment of myocardial viability.

Van Assche LM, Kim HW, Kim RJ.

Methodist Debakey Cardiovasc J. 2013 Jul-Sep;9(3):163-8. Review.

10.

MRI of blood-brain barrier permeability in cerebral ischemia.

Jiang Q, Ewing JR, Chopp M.

Transl Stroke Res. 2012 Mar;3(1):56-64. doi: 10.1007/s12975-011-0133-.

11.

Molecular imaging of experimental abdominal aortic aneurysms.

Ramaswamy AK, Hamilton M 2nd, Joshi RV, Kline BP, Li R, Wang P, Goergen CJ.

ScientificWorldJournal. 2013 Apr 23;2013:973150. doi: 10.1155/2013/973150. Print 2013. Review.

12.

A direct comparison of the sensitivity of CT and MR cardiac perfusion using a myocardial perfusion phantom.

Otton J, Morton G, Schuster A, Bigalke B, Marano R, Olivotti L, Nagel E, Chiribiri A.

J Cardiovasc Comput Tomogr. 2013 Mar-Apr;7(2):117-24. doi: 10.1016/j.jcct.2013.01.016. Epub 2013 Mar 16.

13.

Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation.

Barnes SL, Whisenant JG, Loveless ME, Yankeelov TE.

Pharmaceutics. 2012;4(3):442-78. doi: 10.3390/pharmaceutics4030442.

14.

Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Zhou Z, Lu ZR.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Jan-Feb;5(1):1-18. doi: 10.1002/wnan.1198. Epub 2012 Oct 9. Review.

15.

Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown.

Valdés PA, Moses ZB, Kim A, Belden CJ, Wilson BC, Paulsen KD, Roberts DW, Harris BT.

J Neuropathol Exp Neurol. 2012 Sep;71(9):806-13. doi: 10.1097/NEN.0b013e31826775a1.

16.

Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent.

Santra S, Jativa SD, Kaittanis C, Normand G, Grimm J, Perez JM.

ACS Nano. 2012 Aug 28;6(8):7281-94. doi: 10.1021/nn302393e. Epub 2012 Jul 18.

17.

The degradation and clearance of Poly(N-hydroxypropyl-L-glutamine)-DTPA-Gd as a blood pool MRI contrast agent.

Zhang G, Zhang R, Melancon MP, Wong K, You J, Huang Q, Bankson J, Liang D, Li C.

Biomaterials. 2012 Jul;33(21):5376-83. doi: 10.1016/j.biomaterials.2012.03.081. Epub 2012 Apr 26.

18.

In vivo magnetic resonance imaging of amyloid-β plaques in mice.

Wadghiri YZ, Hoang DM, Wisniewski T, Sigurdsson EM.

Methods Mol Biol. 2012;849:435-51. doi: 10.1007/978-1-61779-551-0_30.

19.

Correction of arterial input function in dynamic contrast-enhanced MRI of the liver.

Wang H, Cao Y.

J Magn Reson Imaging. 2012 Aug;36(2):411-21. doi: 10.1002/jmri.23636. Epub 2012 Mar 5.

20.

Measuring binding of protein to gel-bound ligands using magnetic levitation.

Shapiro ND, Mirica KA, Soh S, Phillips ST, Taran O, Mace CR, Shevkoplyas SS, Whitesides GM.

J Am Chem Soc. 2012 Mar 28;134(12):5637-46. doi: 10.1021/ja211788e. Epub 2012 Mar 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk